Ryan Zimmerman
Stock Analyst at BTIG
(4.07)
# 530
Out of 5,150 analysts
240
Total ratings
56.46%
Success rate
10.22%
Average return
Main Sectors:
Stocks Rated by Ryan Zimmerman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KIDS OrthoPediatrics | Maintains: Buy | $23 → $24 | $18.48 | +29.87% | 11 | Feb 27, 2026 | |
| ORGO Organogenesis Holdings | Maintains: Buy | $9 → $8 | $2.87 | +178.75% | 11 | Feb 27, 2026 | |
| SOLV Solventum | Reiterates: Buy | $100 | $70.40 | +42.05% | 3 | Feb 27, 2026 | |
| ENOV Enovis | Maintains: Buy | $41 → $43 | $25.79 | +66.73% | 2 | Feb 26, 2026 | |
| ALC Alcon | Maintains: Buy | $91 → $92 | $84.27 | +9.17% | 14 | Feb 25, 2026 | |
| GKOS Glaukos | Reiterates: Buy | $131 | $115.37 | +13.55% | 17 | Feb 18, 2026 | |
| TCMD Tactile Systems Technology | Maintains: Buy | $36 → $38 | $30.17 | +25.95% | 6 | Feb 18, 2026 | |
| ZBH Zimmer Biomet Holdings | Reiterates: Buy | $112 | $95.75 | +16.97% | 11 | Feb 10, 2026 | |
| MDAI Spectral AI | Reiterates: Buy | $3 | $1.44 | +108.33% | 3 | Feb 10, 2026 | |
| HUMA Humacyte | Reiterates: Buy | $6 | $1.15 | +421.74% | 7 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $91 | $79.02 | +15.16% | 6 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $410 → $412 | $381.89 | +7.88% | 19 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $616 | $501.18 | +22.91% | 23 | Jan 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $349 | $339.61 | +2.76% | 21 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $24 | $12.99 | +84.76% | 2 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $4.97 | - | 4 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2 → $1.5 | $0.63 | +136.59% | 3 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.47 | - | 6 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $75.67 | - | 2 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $195 | $127.95 | +52.40% | 1 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $34.96 | - | 9 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $26.56 | - | 2 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $13.11 | +75.44% | 1 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $145 → $148 | $113.10 | +30.86% | 7 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.93 | - | 5 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $90.46 | - | 15 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $10.39 | - | 6 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $53 | $19.22 | +175.75% | 7 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $12.87 | - | 2 | Sep 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $200 | $175.37 | +14.04% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $340 → $350 | $242.89 | +44.10% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $128 | $95.60 | +33.89% | 4 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $12.19 | +23.05% | 1 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $17.60 | +138.64% | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $53 | $7.98 | +558.31% | 3 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $29.22 | - | 3 | Apr 2, 2020 |
OrthoPediatrics
Feb 27, 2026
Maintains: Buy
Price Target: $23 → $24
Current: $18.48
Upside: +29.87%
Organogenesis Holdings
Feb 27, 2026
Maintains: Buy
Price Target: $9 → $8
Current: $2.87
Upside: +178.75%
Solventum
Feb 27, 2026
Reiterates: Buy
Price Target: $100
Current: $70.40
Upside: +42.05%
Enovis
Feb 26, 2026
Maintains: Buy
Price Target: $41 → $43
Current: $25.79
Upside: +66.73%
Alcon
Feb 25, 2026
Maintains: Buy
Price Target: $91 → $92
Current: $84.27
Upside: +9.17%
Glaukos
Feb 18, 2026
Reiterates: Buy
Price Target: $131
Current: $115.37
Upside: +13.55%
Tactile Systems Technology
Feb 18, 2026
Maintains: Buy
Price Target: $36 → $38
Current: $30.17
Upside: +25.95%
Zimmer Biomet Holdings
Feb 10, 2026
Reiterates: Buy
Price Target: $112
Current: $95.75
Upside: +16.97%
Spectral AI
Feb 10, 2026
Reiterates: Buy
Price Target: $3
Current: $1.44
Upside: +108.33%
Humacyte
Feb 9, 2026
Reiterates: Buy
Price Target: $6
Current: $1.15
Upside: +421.74%
Feb 9, 2026
Reiterates: Buy
Price Target: $91
Current: $79.02
Upside: +15.16%
Jan 30, 2026
Maintains: Buy
Price Target: $410 → $412
Current: $381.89
Upside: +7.88%
Jan 23, 2026
Reiterates: Buy
Price Target: $616
Current: $501.18
Upside: +22.91%
Jan 16, 2026
Downgrades: Neutral
Price Target: $349
Current: $339.61
Upside: +2.76%
Dec 15, 2025
Reiterates: Buy
Price Target: $24
Current: $12.99
Upside: +84.76%
Nov 20, 2025
Upgrades: Neutral
Price Target: n/a
Current: $4.97
Upside: -
Nov 11, 2025
Maintains: Buy
Price Target: $2 → $1.5
Current: $0.63
Upside: +136.59%
Nov 7, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.47
Upside: -
Oct 21, 2025
Reiterates: Neutral
Price Target: n/a
Current: $75.67
Upside: -
Oct 13, 2025
Maintains: Buy
Price Target: $190 → $195
Current: $127.95
Upside: +52.40%
Sep 17, 2025
Downgrades: Neutral
Price Target: n/a
Current: $34.96
Upside: -
Sep 16, 2025
Reiterates: Neutral
Price Target: n/a
Current: $26.56
Upside: -
Sep 9, 2025
Reiterates: Buy
Price Target: $23
Current: $13.11
Upside: +75.44%
Jul 14, 2025
Maintains: Buy
Price Target: $145 → $148
Current: $113.10
Upside: +30.86%
Jul 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $7.93
Upside: -
May 27, 2025
Downgrades: Neutral
Price Target: n/a
Current: $90.46
Upside: -
Oct 7, 2024
Upgrades: Neutral
Price Target: n/a
Current: $10.39
Upside: -
Jul 15, 2024
Maintains: Buy
Price Target: $46 → $53
Current: $19.22
Upside: +175.75%
Sep 12, 2023
Downgrades: Neutral
Price Target: n/a
Current: $12.87
Upside: -
Apr 17, 2023
Maintains: Buy
Price Target: $195 → $200
Current: $175.37
Upside: +14.04%
Apr 17, 2023
Maintains: Buy
Price Target: $340 → $350
Current: $242.89
Upside: +44.10%
Dec 17, 2021
Maintains: Buy
Price Target: $138 → $128
Current: $95.60
Upside: +33.89%
Nov 22, 2021
Initiates: Buy
Price Target: $15
Current: $12.19
Upside: +23.05%
Sep 23, 2020
Initiates: Buy
Price Target: $42
Current: $17.60
Upside: +138.64%
Aug 14, 2020
Upgrades: Buy
Price Target: $53
Current: $7.98
Upside: +558.31%
Apr 2, 2020
Downgrades: Neutral
Price Target: n/a
Current: $29.22
Upside: -